We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma (LEBEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01412307
Recruitment Status : Unknown
Verified August 2015 by Antonio Pinto, Fondazione Giovanni Pascale.
Recruitment status was:  Active, not recruiting
First Posted : August 9, 2011
Last Update Posted : August 11, 2015
Information provided by (Responsible Party):
Antonio Pinto, Fondazione Giovanni Pascale

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : July 2015
  Estimated Study Completion Date : July 2016